From the publishers of The New England Journal of Medicine
Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.
Some content may require paid access to the site. Subscribe or
purchase a seven-day site pass for the full text of
all our clinical perspectives on medical journal articles, guidelines, and news.
This years Retrovirus Conference did little to alleviate concerns about the previously published association between abacavir use and increased risk for cardiovascular disease.
In two observational studies presented at CROI 2009, the likelihood of HIV transmission in serodiscordant couples was much lower when infected partners were receiving ART than when they were not.
Data presented at the 2009 Retrovirus Conference bring us closer to a definitive answer.
Delaying antiretroviral therapy until after TB treatment has been completed is associated with increased mortality risk.
An experts take on the most clinically relevant findings presented at the conference
The most important HIV-related findings from this years meeting
Studies on these strategies were detailed at this years International AIDS Conference.
Several new agents with high barriers to resistance were described at the 2008 International AIDS Conference.
The tablet under development is bioequivalent to the current soft gel-cap formulation, according to data presented at the 2008 International AIDS Conference.
Five to ten percent of treatment-naive patients in these settings have primary drug resistance, according to data presented at the 2008 International AIDS Conference.